Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 13/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.31 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11394450 | 0.80 | GAA (0.34) | GAAL3MBTL1 | |
| SCHEMBL9687585 | 0.80 | GAA (0.34) | GAAL3MBTL1 | |
| SCHEMBL11394456 | 0.80 | GAA (0.34) | GAAL3MBTL1 | |
| SCHEMBL10543164 | 0.79 | — | — | |
| SCHEMBL11408442 | 0.79 | CTSL (0.37) | NAAACTSLGAAL3MBTL1ASAH1 | |
| SCHEMBL10546010 | 0.79 | NAAA (0.45) | NAAAGAAL3MBTL1ASAH1 | |
| SCHEMBL10550219 | 0.77 | NAAA (0.37) | NAAACTSLGAAL3MBTL1ASAH1 | |
| SCHEMBL10695608 | 0.76 | MEN1 (0.46) | NAAACTSLASAH1MAPTPDE3A | |
| SCHEMBL10680087 | 0.76 | NAAA (0.36) | NAAACTSLGAAL3MBTL1MAPT | |
| SCHEMBL11397441 | 0.76 | CTSL (0.35) | NAAACTSLGAAL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0053815-B1 | 2-OXOAZETIDINE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1985-05-08 | — | — | EP | disclosed |